In a significant milestone for the pharmaceutical industry, South Korean company DongA ST has secured approval from the U.S. Food and Drug Administration (FDA) for its Stelara biosimilar, Imuldosa. This approval marks a major achievement for DongA ST, solidifying its position as a major player in the global biosimilar market..
The Rise of AI in Mental Health In recent years, the world has witnessed a significant shift in how we approach mental health care..
Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!